Jessica Chubak to Tamoxifen
This is a "connection" page, showing publications Jessica Chubak has written about Tamoxifen.
Connection Strength
0.187
-
CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Cancer Causes Control. 2019 Jan; 30(1):103-112.
Score: 0.161
-
Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract. 2012 Nov; 8(6):e149-57.
Score: 0.026